INMB
INmune Bio·NASDAQ
--
--(--)
--
--(--)
INMB fundamentals
INmune Bio (INMB) expects to report earnings on Mar 30, 2026, with estimated revenue of 0 (YoY --), and EPS at -0.26 (YoY +35.00%).
Revenue estimate / YoY
0
--
EPS estimate / YoY
-0.26
+35.00%
Report date
Mar 30, 2026
Earnings Call
4:30 PM on Mar 30, 2026
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
INmune Bio (INMB) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
INmune Bio (INMB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
INmune Bio (INMB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
INmune Bio (INMB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does INmune Bio (INMB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track INmune Bio (INMB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did INmune Bio's management provide for the next earnings period?Did INmune Bio beat or miss consensus estimates last quarter?What is INmune Bio's gross profit margin?What factors drove the changes in INmune Bio's revenue and profit?What is the market's earnings forecast for INmune Bio next quarter?What is INmune Bio's latest dividend and current dividend yield?What were the key takeaways from INmune Bio’s earnings call?What were the key takeaways from INmune Bio's earnings call?
